P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Bibliographic Details
Main Authors:	Hanke T, Gatell J, Cardona P, Gil O, Fernandez-Lloris R, Im E, Saubi N, Joseph J
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

Newborn Mice Vaccination with BCG.HIVA222 + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
by: Narcís Saubi, et al.
Published: (2011-01-01)

HIV-1 specific CD4+ T cell responses in HIV-1 infected subjects undergoing therapeutic immunisation with MVA.HIVA and pTHr.HIVA vaccines
by: Ondondo, Beatrice Omusiro
Published: (2006)

A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants.
by: Muhammed O Afolabi, et al.
Published: (2013-01-01)

Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine
by: Saubi N, et al.
Published: (2012-09-01)

Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.
by: Narcís Saubi, et al.
Published: (2012-01-01)

EXPECTING THE RETURN OF UIN SUMATERA UTARA'S latHIVa IN THE PREVENTION OF HIV AND AIDS IN NORTH SUMATERA
by: Achmad Ramadhan
Published: (2021-01-01)

New plants, new diseases, new practices : the changing face of ethnomedicine in Hiva Oa, Marquesas Islands
by: Dunn, Liloa Makinney
Published: (2011)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
by: Narcís Saubi, et al.
Published: (2020-11-01)

Marine mammals of Easter Island (Rapa Nui) and Salas y Gómez Island (Motu Motiro Hiva), Chile: a review and new records
by: Rodrigo Hucke-Gaete, et al.
Published: (2014-10-01)

New genus and species of lithistid demosponges from submarine caves in Nuku Hiva (Marquesas Islands) and Tahiti Iti (Society Islands), French Polynesia
by: A. Schuster, et al.
Published: (2021-01-01)

Tentative de discrimination des femelles adultes de simulies (Diptera : Simuliidae) à Nuku-Hiva (Archipel des Marquises, Polynésie Française )
by: Séchan Y., et al.
Published: (2000-12-01)

Methodological issues in the geochemical characterisation and morphological analysis of stone tools: a case study from Nuku Hiva, Marquesas Islands, east Polynesia
by: McAlister, Andrew Joseph
Published: (2011)

Assessment of Ciguatera and Other Phycotoxin-Related Risks in Anaho Bay (Nuku Hiva Island, French Polynesia): Molecular, Toxicological, and Chemical Analyses of Passive Samplers
by: Mélanie Roué, et al.
Published: (2020-05-01)

Toxicological Investigations on the Sea Urchin Tripneustes gratilla (Toxopneustidae, Echinoid) from Anaho Bay (Nuku Hiva, French Polynesia): Evidence for the Presence of Pacific Ciguatoxins
by: Hélène Taiana Darius, et al.
Published: (2018-04-01)

Aspects du cycle d'agressivité de Simulium buissoni Roubaud, 1906 (Diptera : Simuliidae) à Nuku-Hiva, Archipel des Marquises (Polynésie Française)
by: Séchan Y., et al.
Published: (2001-03-01)

First endemic arachnid from Isla Sala y Gómez (Motu Motiro Hiva), Chile: a new species of tube-dwelling spider (Araneae: Segestriidae)
by: André Marsola Giroti, et al.
Published: (2020-10-01)

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Detection of Pacific Ciguatoxins in Toxic Samples from Nuku Hiva Island (French Polynesia)
by: Hélène Taiana Darius, et al.
Published: (2017-12-01)

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Clinical Characterization and Follow-Up of a Mass Poisoning Event in Nuku Hiva Island (French Polynesia)
by: Clémence Mahana iti Gatti, et al.
Published: (2018-02-01)

Répartition de Simulium buissoni Roubaud, 1906 et S . sechani Craig & Fossati, 1995 (Diptera: Simuliidae) à Nuku-Hiva et Eiao (Archipel des Marquises, Polynésie Française)
by: Séchan Y., et al.
Published: (2000-12-01)

Anti-vector immune responses to an MVA vaccine
by: Muller, Tracey
Published: (2015)

Interleukin-17 in Antifungal Immunity
by: Florian Sparber, et al.
Published: (2019-04-01)

Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption in Mycobacterium bovis BCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors
by: Joan Joseph, et al.
Published: (2010-01-01)

Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
by: Jorge Sanchez, et al.
Published: (2020-11-01)

Th17 cells and IL-17 in protective immunity to vaginal candidiasis.
by: Donatella Pietrella, et al.
Published: (2011-01-01)

A prime-boost immunization with rBCG expressing HIV-1 Gag, RT and gp120 and SAAVI MVA-C elicits immune responses in blood and MALT of rhesus macaques
by: Chege GK, et al.
Published: (2012-09-01)

Th17 Cells in Immunity and Autoimmunity
by: Simone Kennedy Bedoya, et al.
Published: (2013-01-01)

Pétrogenèse de laves différenciées en contexte intraplaque océanique et hétérogénéité géochimique au niveau du point chaud des Marquises (Polynésie Française) : étude des îles de Ua Pou et de Nuku Hiva
by: LEGENDRE, Christelle
Published: (2003)

Immune status of children with complications of BCG/BCG-M vaccination
by: T. A. Sevostyanova, et al.
Published: (2020-02-01)

Type 17 CD4 (TH17) and CD8 (Tc17) T cells: their function and role in immunity
by: Hung Rong Yen, et al.
Published: (2010)

P19-53 LB. Priming with recombinant BCG expressing HIV-1 Gag or RT and boosting with recombinant MVA induces an effective immune response in mice
by: Williamson A, et al.
Published: (2009-10-01)

MiR-17-92 cluster and immunity
by: George Kuo, et al.
Published: (2019-01-01)

IL-17 in Protective Immunity to Vaginal Candidiasis
by: Baghdad Science Journal
Published: (2016-03-01)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Kathryn T Whelan, et al.
Published: (2009-06-01)

Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia.
by: Yu Hu, et al.
Published: (2011-01-01)

Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
by: Monika Bilska, et al.
Published: (2020-01-01)

Experimental immunity to tuberculosis in rabbits immunized with BCG microsomal fraction /
by: Burns, Robert Malcolm
Published: (1968)

The Humoral Immune Response to BCG Vaccination
by: Rachel Tanner, et al.
Published: (2019-06-01)

Studies of heterologous regimens for HIV-1 vaccines by rBCG and rMVA vectors
by: Hopkins, Richard
Published: (2010)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
by: Kathryn T. Whelan, et al.
Published: (2011-01-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
by: Kathryn T. Whelan, et al.
Published: (2011-01-01)